₹ 14878 / 43 shares
Retail Gain/Listing Gain
Blue Jet Healthcare Limited is a specialty pharmaceutical and healthcare ingredients and intermediates company, offering niche products targeted toward innovator pharmaceutical companies and multi-national generic pharmaceutical companies. The company has manufacturing capabilities in contrast media intermediates and high-intensity sweeteners, including saccharin and its salts.
The company’s operations are primarily organised into three product categories: (i) contrast media intermediates, (ii) high-intensity sweeteners, and (iii) pharma intermediates and active pharmaceutical ingredients (APIs).
In the past three Financial Years and the three months ended June 30, 2023, the company invoiced more than 400 customers in 39 countries. They have built a long-term customer base with innovator pharmaceutical companies and multi-national generic pharmaceutical companies, supported by committed multi-year contracts of up to five years.
With that, let's take a look at the competitive strengths and risk factors for Blue Jet Healthcare Limited:
Here are the key financials for Blue Jet Healthcare Limited:
Particulars (in Rs. million)
How to apply for IPO through ASBA
The Blue Jet Healthcare Limited IPO has an issue size of Rs. 840.27 crores. The IPO opens for subscription on 25th October and closes on 27th October 2023.
Link Intime India Private Limited is the registrar for this IPO.